Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
LLY | Eli Lilly and Company | 64.3 | ¤753,890 | US |
JNJ | Johnson & Johnson | 55.1 | ¤350,501 | US |
MRK | Merck & Co., Inc. | 62.5 | ¤252,635 | US |
TMO | Thermo Fisher Scientific Inc. | 43.3 | ¤201,646 | US |
SYK | Stryker Corporation | 59.1 | ¤140,829 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
AMPH | Amphastar Pharmaceuticals, Inc. | 66.0 | ¤1,835 | US |
HRMY | Harmony Biosciences Holdings, Inc. | 76.8 | ¤1,980 | US |
PINC | Premier, Inc. Class A | 47.7 | ¤2,090 | US |
LMAT | LeMaitre Vascular, Inc. | 61.3 | ¤2,114 | US |
CNMD | CONMED Corporation | 58.8 | ¤2,200 | US |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
UHS | Universal Health Services, Inc. Class B | 59.5 | 30 | US |
CHE | Chemed Corporation | 57.8 | 26 | US |
LLY | Eli Lilly and Company | 64.3 | 24 | US |
ZTS | Zoetis, Inc. Class A | 60.7 | 20 | US |
JNJ | Johnson & Johnson | 55.1 | 19 | US |
TMO | Thermo Fisher Scientific Inc. | 43.3 | 19 | US |
RMD | ResMed Inc. | 70.0 | 17 | US |
HCA | HCA Healthcare Inc | 48.0 | 15 | US |
MDT | Medtronic Plc | 49.7 | 14 | IE |
SYK | Stryker Corporation | 59.1 | 14 | US |
Average Market Cap | ¤76,088 |
Median Market Cap | ¤16,827 |
Avg. 3 Mo. Dollar Vol. | ¤352,280,987 |
Avg. 3 Mo. Trading Vol. | 2,055,079 |
Last Rebalance Date | 09/23/2024 |
Companies Replaced | 19 |
Biggest Sector Increase | Health Care |
Biggest Sector Decrease | Health Care |
Trailing P/E Ratio (12 Mo.) | 20.9 |
Forward P/E Ratio (12 Mo.) | 14.9 |
Price/Book Ratio | 3.3 |
Avg. Revenue Chg. - 3 Yr | 23.8% |
Avg. Op. Income Chg. - 3 Yr. | 40.1% |
Avg. EPS Growth - 3 Yr. | 10.0% |
Avg. EPS Growth - 1 Yr. | 10.8% |
Avg. Operating Margin | 17.9% |
Avg. LT Debt to Total Capital | 41.9% |
Avg. Return on Equity | 18.9% |
Dividend Yield | 0.7% |
US Health Care Index | 58.94 |
United States Of America | 86.67% |
Ireland | 10.0% |
Switzerland | 3.33% |